ArticleNature communications2024

Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.

Elena Ethel Vidal-Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.